23Strands
23Strands is an Australian-owned startup specializing in personalized healthcare through whole genome sequencing and artificial intelligence. The company analyzes the entire human genome to provide comprehensive health insights, integrating genomic, medical, and pharmacological data to support clinical decision-making and improve patient outcomes. Their solutions include precision analysis for IVF, cardiovascular disease, cancer, and women's health, delivered via partnerships with clinicians and integration with electronic health records. 23Strands collaborates with leading research, clinical, and commercial partners to advance genomic medicine and AI-driven biomedical genomics, positioning itself as a leading provider of genomic healthcare solutions in Australia.
23Strands
23Strands is an Australian-owned startup specializing in personalized healthcare through whole genome sequencing and artificial intelligence. The company analyzes the entire human genome to provide comprehensive health insights, integrating genomic, medical, and pharmacological data to support clinical decision-making and improve patient outcomes. Their solutions include precision analysis for IVF, cardiovascular disease, cancer, and women's health, delivered via partnerships with clinicians and integration with electronic health records. 23Strands collaborates with leading research, clinical, and commercial partners to advance genomic medicine and AI-driven biomedical genomics, positioning itself as a leading provider of genomic healthcare solutions in Australia.